|
End-of-day quote
Nasdaq Stockholm
2026-09-11
|
5-day change | 1st Jan Change | ||
| 4.350 SEK | -3.44% |
|
-11.41% | -5.43% |
Company Valuation: Active Biotech AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 275.5 | 254.8 | 165.1 | 115.9 | 121.3 | 114.7 | - | - |
| Change | - | -7.51% | -35.2% | -29.8% | 4.6% | -5.43% | - | - |
| Enterprise Value (EV) | 223.1 | 254.8 | 128.9 | 88.53 | 121.3 | 114.7 | 114.7 | 114.7 |
| Change | - | 14.2% | -49.4% | -31.34% | 36.97% | -5.43% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - | -6.99x |
| EV / Revenue | - | - | - | - | - | - | - | -6.99x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -3.3x | 6.91x | 2.28x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.45x | 6.3x | 2.21x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | -16.4 |
| EBITDA 1 | -48.5 | -56.4 | -44.8 | -38.2 | -36 | -34.8 | 16.6 | 50.2 |
| EBIT 1 | -49.8 | -57.9 | -46.5 | -39.8 | -37.6 | -33.2 | 18.2 | 51.8 |
| Net income 1 | -49.8 | -58.4 | -45.8 | -39.4 | -37.32 | -33.2 | 18.2 | 51.8 |
| Net Debt | -52.37 | - | -36.2 | -27.4 | - | - | - | - |
| Reference price 2 | 126.400 | 96.200 | 45.650 | 10.880 | 4.600 | 4.350 | 4.350 | 4.350 |
| Nbr of stocks (in thousands) | 2,180 | 2,649 | 3,617 | 10,655 | 26,361 | 26,361 | - | - |
| Announcement Date | 3/25/22 | 2/9/23 | 2/8/24 | 2/13/25 | 4/1/26 | - | - | - |
1SEK in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 11.83M | |
| 19.64x | 6.93x | 13.92x | 1.51% | 66.93B | |
| 31.94x | 9.24x | 44.54x | 0.04% | 61.97B | |
| -79.21x | 15.29x | -73.77x | -.--% | 28.27B | |
| 28.46x | 6.03x | 15.64x | -.--% | 24.59B | |
| -14.63x | 5.3x | -6.66x | -.--% | 24.3B | |
| 26.45x | 4.98x | 16.56x | -.--% | 19.41B | |
| 48.28x | 17.79x | 36.09x | 0.31% | 16.77B | |
| 1225.47x | 35.26x | 769.42x | -.--% | 14.18B | |
| 17.33x | 5.16x | 12.04x | -.--% | 13.91B | |
| Average | 144.86x | 11.77x | 91.98x | 0.21% | 27.03B | |
| Weighted average by Cap. | 75.23x | 10.03x | 51.17x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACTI Stock
- Valuation Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
